This book explicitly addresses policy options in a democratic society regarding cognitive enhancement drugs and devices. The book offers an in-depth case by case analysis of existing and emerging cognitive neuroenhancement technologies and canvasses a distinct political neuroethics approach. The author provides an argument on the much debated issue of fairness of cognitive enhancement practices and tackles the tricky issue of how to respect preferences of citizens opposing and those preferring enhancement. The author persuasively argues the necessity of a laws and regulations regarding the use of cognitive enhancers. He also argues that the funds for those who seek cognitive enhancement should be allocated free of charge to the least advantaged. The work argues that the notion of autonomy has been mistakenly associated with the metaphysical concept of free will, and offers a political definition of autonomy to clarify how responsibility is implicitly grounded in the legal and political system. As such, this book is an essential read for everyone interested in neuroethics, and a valuable resource for policy makers, as well as scholars and students in philosophy, law, psychiatry and neuroscience.

This book explicitly addresses policy options in a democratic society regarding cognitive enhancement drugs and devices. The book offers an in-depth case by case analysis of existing and emerging cognitive neuroenhancement technologies and canvasses a distinct political neuroethics approach. The author provides an argument on the much debated issue of fairness of cognitive enhancement practices and tackles the tricky issue of how to respect preferences of citizens opposing and those preferring enhancement. The author persuasively argues the necessity of a laws and regulations regarding the use of cognitive enhancers. He also argues that the funds for those who seek cognitive enhancement should be allocated free of charge to the least advantaged. The work argues that the notion of autonomy has been mistakenly associated with the metaphysical concept of free will, and offers a political definition of autonomy to clarify how responsibility is implicitly grounded in the legal and political system. As such, this book is an essential read for everyone interested in neuroethics, and a valuable resource for policy makers, as well as scholars and students in philosophy, law, psychiatry and neuroscience.

This book addresses current issues in the neuroscience and ethics of dementia care, including philosophical as well as ethical legal, and social issues (ELSIs), issues in clinical, institutional, and private care-giving, and international perspectives on dementia and care innovations. As such, it is a must-read for anyone interested in a well-researched, thought-provoking overview of current issues in dementia diagnosis, care, and social and legal policy. All contributions reflect the latest neuroscientific research on dementia, either broadly construed or in terms of the etiologies and symptoms of particular forms of dementia. Given its interdisciplinary and international scope, its depth of research, and its qualitative emphasis, the book represents a valuable addition to the available literature on neuroethics, gerontology, and neuroscientific memory research.

There is a growing discussion concerning the relationship between neuroethical reflections and cultural diversity, which is among the most impactful factors in shaping neuroethics, both as a scientific discipline and a social enterprise. The impacts of culture on science and its public perception are particularly relevant to neuroethics, which aims to facilitate the creation of an interface between neuroscience and society at large. Time is ripe for neuroethics to review the influence of the culturally specific contexts from which it originated (i.e. North America and Western Europe) and to also include other cultural perspectives in the discussion. This book illustrates a convergent approach among different cultures in identifying the main issues raised by neuroscience and emerging technologies. This should be taken as a starting point for advancing in the search for shared solutions, which are, if not definitive, at least sufficiently reliable to be translated into democratic deliberative processes.

The Routledge Handbook of the Ethics of Human Enhancement provides readers with a philosophically rich and scientifically grounded analysis of human enhancement and its ethical implications. A landmark in the academic literature, the volume covers human enhancement in genetic engineering, neuroscience, synthetic biology, regenerative medicine, bioengineering, and many other fields. The Handbook includes a diverse and multifaceted collection of 30 chapters—all appearing here in print for the first time— that reveal the fundamental ethical challenges related to human enhancement. The chapters have been written by internationally recognized leaders in the field and are organized into seven parts: Historical Background and Key Concepts Human Enhancement and Human Nature Physical Enhancement Cognitive Enhancement Mood Enhancement and Moral Enhancement Human Enhancement and Medicine Legal, Social, and Political Implications The depth and topical range of the Handbook makes it an essential resource for upper-level undergraduates, graduate students, and postdoctoral fellows in a broad variety of disciplinary areas. Furthermore, it is an authoritative reference for basic scientists, philosophers, engineers, physicians, lawyers, and other professionals who work on the topic of human enhancement.

A cross-disciplinary approach is offered to consider the challenge of emerging technologies designed to enhance human bodies and minds. Perspectives from philosophy, ethics, law, and policy are applied to a wide variety of enhancements, including integration of technology within human bodies, as well as genetic, biological, and pharmacological modifications. Humans may be permanently or temporarily enhanced with artificial parts by manipulating (or reprogramming) human DNA and through other enhancement techniques (and combinations thereof). We are on the cusp of significantly modifying (and perhaps improving) the human ecosystem. This evolution necessitates a continuing effort to re-evaluate current laws and, if appropriate, to modify such laws or develop new laws that address enhancement technology. A legal, ethical, and policy response to current and future human enhancements should strive to protect the rights of all involved and to recognize the responsibilities of humans to other conscious and living beings, regardless of what they look like or what abilities they have (or lack). A potential ethical approach is outlined in which rights and responsibilities should be respected even if enhanced humans are perceived by non-enhanced (or less-enhanced) humans as “no longer human” at all.

In this volume the authors explore the landscape of thought on the ethical and policy implications of Brain Computer Interface (BCI) technology. BCI technology is a promising and rapidly advancing research area. Recent developments in the technology, based on animal and human studies, allow for the restoration and potential augmentation of faculties of perception and physical movement, and even the transfer of information between brains. Brain activity can be interpreted through both invasive and non-invasive monitoring devices, allowing for novel, therapeutic solutions for individuals with disabilities and for other non-medical applications. However, a number of ethical and policy issues have been identified from the use of BCI technology, with the potential for near-future advancements in the technology to raise unique new ethical and policy questions that society has never grappled with before. The volume has three parts: 1) Past, Present and Future of BCI technology, 2) Ethical and Philosophical Issues and 3) Legal and Policy Implications. The rich and detailed picture of the field of BCI ethics with contributors from various fields and backgrounds, from academia and from the commercial sphere may serve as an introductory textbook into the neuroethics of BCI, or as a resource for neuroscientists, engineers, and medical practitioners to gain additional insight into the ethical and policy implications of their work.

Cognitive enhancement is the use of drugs, biotechnological strategies or other means by healthy individuals aiming at the improvement of cognitive functions such as vigilance, concentration or memory without any medical need. In particular, the use of pharmacological substances (caffeine, prescription drugs or illicit drugs) has received considerable attention during the last few years. Currently, however, little is known concerning the use of cognitive enhancers, their effects in healthy individuals and the place and function of cognitive enhancement in everyday life. The purpose of the book is to give an overview of the current research on cognitive enhancement and to provide in-depth insights into the interdisciplinary debate on cognitive enhancement.

There is a growing literature in neuroethics dealing with cognitive neuro-enhancement for healthy adults. However, discussions on this topic tend to focus on abstract theoretical positions while concrete policy proposals and detailed models are scarce. Furthermore, discussions appear to rely solely on data from the US or UK, while international perspectives are mostly non-existent. This volume fills this gap and addresses issues on cognitive enhancement comprehensively in three important ways: 1) it examines the conceptual implications stemming from competing points of view about the nature and goals of enhancement; 2) it addresses the ethical, social, and legal implications of neuroenhancement from an international and global perspective including contributions from scholars in Africa, Asia, Australia, Europe, North America, and South America; and 3) it discusses and analyzes concrete legal issues and policy options tailored to specific contexts.

Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors addresses the gap that exists in research on the topic, gathering multidisciplinary knowledge and tools that help the reader understand the basics of cognitive enhancement. It also provides assistance in designing procedures and pharmacological approaches to further the use of novel cognitive enhancers, a field that offers potential benefit to a variety of populations, including those with neurologic and psychiatric disorders, mild aging-related cognitive impairment, and those who want to improve intellectual performance. The text builds on our knowledge of the molecular/cellular basis of cognitive function, offering the technological developments that may soon enhance cognition. Separate sections cover enhancement drugs, environmental conditions, and genetic factors in terms of both human and animal studies, including both healthy/young and aging/diseased individuals. - Provides a multidisciplinary knowledge, enabling a further understanding of cognitive enhancement - Offers coverage of the pharmacologic, environmental, and genetic factors relevant to the topic - Discusses cognitive enhancement from the perspective of both healthy and diseased or aging populations - Topics are discussed in terms of both human and animal studies